Corgenix Retains Bathgate McColley Capital Group, LLC; Denver Firm to Provide Broad Range of Investment Banking Services to Corgenix

Apr 16, 2001, 01:00 ET from Corgenix Medical Corporation

    DENVER, April 16 /PRNewswire/ -- Corgenix Medical Corporation
 (OTC Bulletin Board:   COGX) announced today that it had signed an agreement
 with Englewood, Colorado based Bathgate McColley Capital Group, LLC ("BMCG")
 to provide a wide range of financial and investment banking services.
     Douglass T. Simpson, President of Corgenix, stated: "We are extremely
 pleased to be working with Bathgate McColley.  We evaluated a number of
 alternatives but selected this firm because of its outstanding track record in
 assisting rapidly growing companies.  The depth of experience of their team
 especially impressed us.  Their knowledge of the medical industry and
 experience in assisting medical companies will serve us well, and we look
 forward to working with them to maximize value for Corgenix shareholders."
     Steve Bathgate and Gene McColley, the Managing Directors of BMCG, stated,
 "Corgenix has demonstrated consistent and increasing profitability over the
 past two years and this has gone unnoticed by the investment community.  This
 agreement with Corgenix will allow us to build shareholder value by working
 with management and the Board of Directors to accelerate Corgenix's growth by
 developing and implementing organic and acquisitive investment banking
 strategies.  We believe that Corgenix has the management in place to
 substantially increase market value, and we look forward to acting as a
 catalyst in this effort.
     "We believe that Corgenix has positioned itself to become an attractive
 partner to other developers of biomedical products.  We intend to use market
 knowledge and contacts to identify companies that have complementary product
 and distribution methods to enter into joint ventures or to make acquisitions.
     "The products developed and manufactured by Corgenix improve patient
 diagnosis and care, and in certain instances, may also have the potential to
 be used by the pharmaceutical and biotechnology industry as diagnostic tools
 during the drug development process.  We believe that this exciting aspect of
 Corgenix's business has not been given adequate exposure in the investment
 community, and we intend to work closely with the Company and various
 participants in the biomedical and securities industry to obtain greater
 exposure of this asset of the company in the future."
 
     Corgenix Medical Corporation is based in metropolitan Denver, with its
 international marketing office near Cambridge, England.  Corgenix is focused
 on the development and promotion of specialized diagnostic test kits for
 vascular diseases and immunological disorders.  Corgenix diagnostic products
 are commercialized for use in clinical laboratories worldwide.
 health-outfitters.com, Inc., a subsidiary of Corgenix, focuses on consumer
 healthcare products.
 
     Bathgate McColley Capital Group, LLC is a merchant-banking firm based in
 Englewood, Colorado that focuses on capital formation for emerging growth
 companies.  BMCG and its principals have assisted emerging companies in
 raising in excess of $75 million over the past six years.  BMCG is a member of
 the NASD, CRD Number 038923.
 
     Statements in this release that are not strictly historical are "forward-
 looking" statements within the meaning of the Private Securities Litigation
 Reform Act of 1995, and should be considered as subject to various risks and
 uncertainties that could cause actual results to differ materially from those
 anticipated.  Further risks are detailed in the Company's filings with the
 Securities and Exchange Commission, including those set forth in the Company's
 most recent Annual and Quarterly Reports on Form 10-KSB and Form 10-QSB.
 
     Complete copies of the Corgenix Medical Corporation Form 10-KSB and 10-QSB
 are available at www.sec.gov or can be obtained by contacting Chris Wolfe,
 investor relations manager of Corgenix: phone (303) 457-4345 ext 147, or email
 at cwolfe@corgenix.com.  For further information on Bathgate McColley Capital
 Group contact Vicki Barone at (303)694-0862.
 
 

SOURCE Corgenix Medical Corporation
    DENVER, April 16 /PRNewswire/ -- Corgenix Medical Corporation
 (OTC Bulletin Board:   COGX) announced today that it had signed an agreement
 with Englewood, Colorado based Bathgate McColley Capital Group, LLC ("BMCG")
 to provide a wide range of financial and investment banking services.
     Douglass T. Simpson, President of Corgenix, stated: "We are extremely
 pleased to be working with Bathgate McColley.  We evaluated a number of
 alternatives but selected this firm because of its outstanding track record in
 assisting rapidly growing companies.  The depth of experience of their team
 especially impressed us.  Their knowledge of the medical industry and
 experience in assisting medical companies will serve us well, and we look
 forward to working with them to maximize value for Corgenix shareholders."
     Steve Bathgate and Gene McColley, the Managing Directors of BMCG, stated,
 "Corgenix has demonstrated consistent and increasing profitability over the
 past two years and this has gone unnoticed by the investment community.  This
 agreement with Corgenix will allow us to build shareholder value by working
 with management and the Board of Directors to accelerate Corgenix's growth by
 developing and implementing organic and acquisitive investment banking
 strategies.  We believe that Corgenix has the management in place to
 substantially increase market value, and we look forward to acting as a
 catalyst in this effort.
     "We believe that Corgenix has positioned itself to become an attractive
 partner to other developers of biomedical products.  We intend to use market
 knowledge and contacts to identify companies that have complementary product
 and distribution methods to enter into joint ventures or to make acquisitions.
     "The products developed and manufactured by Corgenix improve patient
 diagnosis and care, and in certain instances, may also have the potential to
 be used by the pharmaceutical and biotechnology industry as diagnostic tools
 during the drug development process.  We believe that this exciting aspect of
 Corgenix's business has not been given adequate exposure in the investment
 community, and we intend to work closely with the Company and various
 participants in the biomedical and securities industry to obtain greater
 exposure of this asset of the company in the future."
 
     Corgenix Medical Corporation is based in metropolitan Denver, with its
 international marketing office near Cambridge, England.  Corgenix is focused
 on the development and promotion of specialized diagnostic test kits for
 vascular diseases and immunological disorders.  Corgenix diagnostic products
 are commercialized for use in clinical laboratories worldwide.
 health-outfitters.com, Inc., a subsidiary of Corgenix, focuses on consumer
 healthcare products.
 
     Bathgate McColley Capital Group, LLC is a merchant-banking firm based in
 Englewood, Colorado that focuses on capital formation for emerging growth
 companies.  BMCG and its principals have assisted emerging companies in
 raising in excess of $75 million over the past six years.  BMCG is a member of
 the NASD, CRD Number 038923.
 
     Statements in this release that are not strictly historical are "forward-
 looking" statements within the meaning of the Private Securities Litigation
 Reform Act of 1995, and should be considered as subject to various risks and
 uncertainties that could cause actual results to differ materially from those
 anticipated.  Further risks are detailed in the Company's filings with the
 Securities and Exchange Commission, including those set forth in the Company's
 most recent Annual and Quarterly Reports on Form 10-KSB and Form 10-QSB.
 
     Complete copies of the Corgenix Medical Corporation Form 10-KSB and 10-QSB
 are available at www.sec.gov or can be obtained by contacting Chris Wolfe,
 investor relations manager of Corgenix: phone (303) 457-4345 ext 147, or email
 at cwolfe@corgenix.com.  For further information on Bathgate McColley Capital
 Group contact Vicki Barone at (303)694-0862.
 
 SOURCE  Corgenix Medical Corporation